CrisprBits will use the new funding to grow the commercial rollout of its PathCrisp diagnostic platform and expand test manufacturing for human health, food safety, and animal health. It is also building a CRISPR-based strain engineering platform, starting with improving biofuel production.
Advertisment
Advertisment
Top Stories
Latest Stories
HomeAuthorsJitendra swami